1
|
Zamore PD and Haley B: Ribo-gnome: the big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Bhan A and Mandal SS: Long noncoding RNAs:
emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: a new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:38–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao
W and Cui Q: An analysis of human microRNA and disease
associations. PLoS One. 3:e34202008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Plaisier CL, Pan M and Baliga NS: A
miRNA-regulatory network explains how dysregulated miRNAs perturb
oncogenic processes across diverse cancers. Genome Res.
22:2302–2314. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: the Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jeggari A, Marks DS and Larsson E:
miRcode: a map of putative microRNA target sites in the long
non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: a clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Taylor LP: Diagnosis, treatment, and
prognosis of glioma: five new things. Neurology. 75(Suppl 1):
S28–S32. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
21
|
Yan Y, Zhang L, Jiang Y, Xu T, Mei Q, Wang
H, Qin R, Zou Y, Hu G, Chen J, et al: LncRNA and mRNA interaction
study based on transcriptome profiles reveals potential core genes
in the pathogenesis of human glioblastoma multiforme. J Cancer Res
Clin Oncol. 141:827–838. 2015. View Article : Google Scholar
|
22
|
Kim TM, Huang W, Park R, Park PJ and
Johnson MD: A developmental taxonomy of glioblastoma defined and
maintained by MicroRNAs. Cancer Res. 71:3387–3399. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al The Gene Ontology Consortium: Gene ontology: tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32:D277–D280. 2004. View Article : Google Scholar :
|
26
|
Prieto C, Risueño A, Fontanillo C and De
las Rivas J: Human gene coexpression landscape: confident network
derived from tissue transcriptomic profiles. PLoS One. 3:e39112008.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Barabási AL and Oltvai ZN: Network
biology: understanding the cell's functional organization. Nat Rev
Genet. 5:101–113. 2004. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013.PubMed/NCBI
|
31
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Pilyugin M and Irminger-Finger I: Long
non-coding RNA and microRNAs might act in regulating the expression
of BARD1 mRNAs. Int J Biochem Cell Biol. 54:356–367. 2014.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Fan YC, Mei PJ, Chen C, Miao FA, Zhang H
and Li ZL: MiR-29c inhibits glioma cell proliferation, migration,
invasion and angiogenesis. J Neurooncol. 115:179–188. 2013.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Chung HJ, Choi YE, Kim ES, Han YH, Park MJ
and Bae IH: miR-29b attenuates tumorigenicity and stemness
maintenance in human glioblastoma multiforme by directly targeting
BCL2L2. Oncotarget. 6:18429–18444. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Fowler A, Thomson D, Giles K, Maleki S,
Mreich E, Wheeler H, Leedman P, Biggs M, Cook R, Little N, et al:
miR-124a is frequently down-regulated in glioblastoma and is
involved in migration and invasion. Eur J Cancer. 47:953–963. 2011.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Besse A, Sana J, Lakomy R, Kren L, Fadrus
P, Smrcka M, Hermanova M, Jancalek R, Reguli S, Lipina R, et al:
MiR-338-5p sensitizes glioblastoma cells to radiation through
regulation of genes involved in DNA damage response. Tumour Biol.
37:7719–7727. 2015. View Article : Google Scholar : PubMed/NCBI
|
38
|
Yue S, Wang L, Zhang H, Min Y, Lou Y, Sun
H, Jiang Y, Zhang W, Liang A, Guo Y, et al: miR-139-5p suppresses
cancer cell migration and invasion through targeting ZEB1 and ZEB2
in GBM. Tumour Biol. 36:6741–6749. 2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Qiu S, Lin S, Hu D, Feng Y, Tan Y and Peng
Y: Interactions of miR-323/miR-326/miR-329 and
miR-130a/miR-155/miR-210 as prognostic indicators for clinical
outcome of glioblastoma patients. J Transl Med. 11:10–21. 2013.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Rivera-Díaz M, Miranda-Román MA, Soto D,
Quintero-Aguilo M, Ortiz-Zuazaga H, Marcos-Martinez MJ and
Vivas-Mejía PE: MicroRNA-27a distinguishes glioblastoma multiforme
from diffuse and anaplastic astrocytomas and has prognostic value.
Am J Cancer Res. 5:201–218. 2014.
|
41
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar
|
42
|
Koshkin PA, Chistiakov DA, Nikitin AG,
Konovalov AN, Potapov AA, Usachev DY, Pitskhelauri DI, Kobyakov GL,
Shishkina LV and Chekhonin VP: Analysis of expression of microRNAs
and genes involved in the control of key signaling mechanisms that
support or inhibit development of brain tumors of different grades.
Clin Chim Acta. 430:55–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
43
|
Turner KM, Sun Y, Ji P, Granberg KJ,
Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, et al:
Genomically amplified Akt3 activates DNA repair pathway and
promotes glioma progression. Proc Natl Acad Sci USA. 112:3421–3426.
2015. View Article : Google Scholar : PubMed/NCBI
|
44
|
Jain R, Poisson L, Narang J, Scarpace L,
Rosenblum ML, Rempel S and Mikkelsen T: Correlation of perfusion
parameters with genes related to angiogenesis regulation in
glioblastoma: a feasibility study. AJNR Am J Neuroradiol.
33:1343–1348. 2012. View Article : Google Scholar : PubMed/NCBI
|